Published in Ann Intern Med on August 19, 2003
Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48
Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int (2011) 6.01
Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol (2009) 4.16
Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med (2008) 3.71
Epidemiology of chronic kidney disease in children. Pediatr Nephrol (2011) 3.42
Chronic kidney disease in children: the global perspective. Pediatr Nephrol (2007) 3.05
Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP). Arch Intern Med (2012) 2.74
Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ (2006) 2.29
Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol (2009) 2.22
Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan. J Am Soc Nephrol (2008) 1.93
Audit-based education lowers systolic blood pressure in chronic kidney disease: the Quality Improvement in CKD (QICKD) trial results. Kidney Int (2013) 1.90
Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol (2009) 1.86
Renal autoregulation: new perspectives regarding the protective and regulatory roles of the underlying mechanisms. Am J Physiol Regul Integr Comp Physiol (2006) 1.79
Blood pressure components and the risk for end-stage renal disease and death in chronic kidney disease. Clin J Am Soc Nephrol (2009) 1.72
Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation (2016) 1.69
Serum potassium and outcomes in CKD: insights from the RRI-CKD cohort study. Clin J Am Soc Nephrol (2010) 1.69
Angiotensin blockade in late autosomal dominant polycystic kidney disease. N Engl J Med (2014) 1.64
Diagnosed hypertension in Canada: incidence, prevalence and associated mortality. CMAJ (2011) 1.62
Primary care management of chronic kidney disease. J Gen Intern Med (2010) 1.52
Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis. CMAJ (2013) 1.43
BP, cardiovascular disease, and death in the Folic Acid for Vascular Outcome Reduction in Transplantation trial. J Am Soc Nephrol (2014) 1.42
Blood pressure and chronic kidney disease progression in a multi-racial cohort: the Multi-Ethnic Study of Atherosclerosis. J Hum Hypertens (2013) 1.38
Evidence-based practice guideline for the treatment of CKD. Clin Exp Nephrol (2009) 1.29
Albumin testing in urine using a smart-phone. Lab Chip (2013) 1.23
Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review. Clin Exp Nephrol (2008) 1.21
Effects of structured versus usual care on renal endpoint in type 2 diabetes: the SURE study: a randomized multicenter translational study. Diabetes Care (2009) 1.20
Inflammation and cachexia in chronic kidney disease. Pediatr Nephrol (2010) 1.20
Integrating albuminuria and GFR in the assessment of diabetic nephropathy. Nat Rev Nephrol (2009) 1.19
Chronic kidney disease perspectives in Japan and the importance of urinalysis screening. Clin Exp Nephrol (2008) 1.19
IgM contributes to glomerular injury in FSGS. J Am Soc Nephrol (2013) 1.17
Characteristics of uninsured Americans with chronic kidney disease. J Gen Intern Med (2009) 1.15
IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The IMPERATIVE renal analysis. Arch Med Sci (2011) 1.12
Public health consequences of chronic kidney disease. Clin Pharmacol Ther (2009) 1.07
Risk factors for ESRD in individuals with preserved estimated GFR with and without albuminuria: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2013) 1.06
Clinical correlates of ambulatory BP monitoring among patients with CKD. Clin J Am Soc Nephrol (2013) 1.03
Advances in CKD detection and determination of prognosis: executive summary of the National Kidney Foundation-Kidney Early Evaluation Program (KEEP) 2012 annual data report. Am J Kidney Dis (2013) 1.02
Suboptimal blood pressure control in chronic kidney disease stage 3: baseline data from a cohort study in primary care. BMC Fam Pract (2013) 1.00
Time-updated systolic blood pressure and the progression of chronic kidney disease: a cohort study. Ann Intern Med (2015) 0.99
Kidney function can improve in patients with hypertensive CKD. J Am Soc Nephrol (2012) 0.99
A giant inguinoscrotal bladder hernia as a cause of chronic renal failure: A rare case. Int J Surg Case Rep (2013) 0.98
Hypertension in children with chronic kidney disease: pathophysiology and management. Pediatr Nephrol (2007) 0.97
Impact of serum uric acid on renal function and cardiovascular events in hypertensive patients treated with losartan. Hypertens Res (2012) 0.96
Pressure-induced renal injury in angiotensin II versus norepinephrine-induced hypertensive rats. Hypertension (2009) 0.95
Characterizing pre-dialysis care in the era of eGFR reporting: a cohort study. BMC Nephrol (2011) 0.95
Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension. Pediatr Cardiol (2007) 0.95
Association of genetic variants with chronic kidney disease in Japanese individuals. Clin J Am Soc Nephrol (2009) 0.93
Kidney function and systolic blood pressure new insights from cystatin C: data from the Heart and Soul Study. Am J Hypertens (2006) 0.93
Renal complications of Fabry disease in children. Pediatr Nephrol (2012) 0.93
Improving evidence-based primary care for chronic kidney disease: study protocol for a cluster randomized control trial for translating evidence into practice (TRANSLATE CKD). Implement Sci (2013) 0.92
Cardiovascular disease in patients with chronic kidney disease. Vasc Health Risk Manag (2009) 0.92
Early change in proteinuria as a surrogate end point for kidney disease progression: an individual patient meta-analysis. Am J Kidney Dis (2014) 0.92
Recognition and management of chronic kidney disease in an elderly ambulatory population. J Gen Intern Med (2008) 0.90
The association between a Mediterranean-style diet and kidney function in the Northern Manhattan Study cohort. Clin J Am Soc Nephrol (2014) 0.89
Relationship between blood pressure and incident chronic kidney disease in hypertensive patients. Clin J Am Soc Nephrol (2011) 0.87
Treatment strategies in patients with chronic renal disease: ACE inhibitors, angiotensin receptor antagonists, or both? Pediatr Nephrol (2004) 0.87
Resistant hypertension in nondialysis chronic kidney disease. Int J Hypertens (2013) 0.86
Interplay of vitamin D, erythropoiesis, and the renin-angiotensin system. Biomed Res Int (2015) 0.86
Ace inhibitor therapy for heart failure in patients with impaired renal function: a review of the literature. Heart Fail Rev (2013) 0.86
Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease. Clin Exp Nephrol (2007) 0.86
Documentation and management of CKD in rural primary care. Clin J Am Soc Nephrol (2013) 0.86
Safety and efficacy of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Japanese patients with hypertension and renal dysfunction. Hypertens Res (2015) 0.86
Prevalence, determinants, and management of chronic kidney disease in Karachi, Pakistan - a community based cross-sectional study. BMC Nephrol (2014) 0.86
Lupus nephritis: an update. Clin Exp Nephrol (2015) 0.86
Hypertension in Cardiovascular and Kidney Disease. Cardiorenal Med (2011) 0.85
Genetic polymorphisms of the RAS-cytokine pathway and chronic kidney disease. Pediatr Nephrol (2008) 0.84
Application of direct renin inhibition to chronic kidney disease. Cardiovasc Drugs Ther (2010) 0.84
Inhibition of RAS in diabetic nephropathy. Int J Nephrol Renovasc Dis (2015) 0.84
Effects of blood pressure on renal and cardiovascular outcomes in Asian patients with type 2 diabetes and overt nephropathy: a post hoc analysis (ORIENT-blood pressure). Nephrol Dial Transplant (2015) 0.84
Optimizing blood pressure control in patients with chronic kidney disease. Proc (Bayl Univ Med Cent) (2010) 0.83
Early change in proteinuria as a surrogate outcome in kidney disease progression: a systematic review of previous analyses and creation of a patient-level pooled dataset. Nephrol Dial Transplant (2010) 0.83
Hypertension and chronic kidney disease progression: why the suboptimal outcomes? Am J Med (2012) 0.83
Healthy behaviors, risk factor control and awareness of chronic kidney disease. Am J Nephrol (2013) 0.82
Smoking and risk of kidney failure in the Singapore Chinese health study. PLoS One (2013) 0.82
Educational paper: Progression in chronic kidney disease and prevention strategies. Eur J Pediatr (2012) 0.82
Blood pressure-renal blood flow relationships in conscious angiotensin II- and phenylephrine-infused rats. Am J Physiol Renal Physiol (2013) 0.81
Differential diagnosis of glomerular disease: a systematic and inclusive approach. Am J Nephrol (2013) 0.81
Effects of antiproteinuric intervention on elevated connective tissue growth factor (CTGF/CCN-2) plasma and urine levels in nondiabetic nephropathy. Clin J Am Soc Nephrol (2011) 0.81
Influence of T-calcium channel blocker treatment on deterioration of renal function in chronic kidney disease. Heart Vessels (2009) 0.80
Chronic kidney disease management in an academic internal medicine clinic. Clin Exp Nephrol (2009) 0.80
Long-term effects of aldosterone blockade in resistant hypertension associated with chronic kidney disease. J Hum Hypertens (2011) 0.80
Metabolic syndrome, chronic kidney disease, and cardiovascular disease: a dynamic and life-threatening triad. Cardiol Res Pract (2011) 0.80
Risk factors for loss of residual renal function in children treated with chronic peritoneal dialysis. Kidney Int (2015) 0.80
Ethnic differences in the association between blood pressure components and chronic kidney disease in middle aged and older Asian adults. BMC Nephrol (2013) 0.80
2013 Korean Society of Hypertension guidelines for the management of hypertension: part III-hypertension in special situations. Clin Hypertens (2015) 0.79
Chronic kidney disease in the elderly: evaluation and management. Clin Pract (Lond) (2015) 0.79
General practitioners' knowledge and approach to chronic kidney disease in Karachi, Pakistan. Indian J Nephrol (2013) 0.79
Optimal predialysis care. NDT Plus (2008) 0.79
Physical activity and risk of end-stage kidney disease in the Singapore Chinese Health Study. Nephrology (Carlton) (2015) 0.79
Managing cardiovascular risk in people with chronic kidney disease: a review of the evidence from randomized controlled trials. Ther Adv Chronic Dis (2011) 0.79
Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy. BMC Nephrol (2017) 0.78
Optimal proteinuria target for renoprotection in patients with IgA nephropathy. PLoS One (2014) 0.78
Corticosteroids in IgA Nephropathy: Lessons from Recent Studies. J Am Soc Nephrol (2016) 0.78
Evaluating risk of ESRD in the urban poor. J Am Soc Nephrol (2014) 0.78
Factors that favor the occurrence of cough in patients treated with ramipril--a pharmacoepidemiological study. Med Sci Monit (2012) 0.78
Cardiovascular and Renal Links along the Cardiorenal Continuum. Int J Nephrol (2011) 0.78
Challenges and scientific considerations in hypertension management reflected in the 2012 recommendations of the Canadian Hypertension Education Program. Open Med (2012) 0.78
Association of high blood pressure with renal insufficiency: role of albuminuria, from NHANES, 1999-2006. PLoS One (2012) 0.78
Risk of hyperkalemia in patients with moderate chronic kidney disease initiating angiotensin converting enzyme inhibitors or angiotensin receptor blockers: a randomized study. BMC Res Notes (2013) 0.78
The association of chronic kidney disease complications by albuminuria and glomerular filtration rate: a cross-sectional analysis. Clin Nephrol (2013) 0.78
A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41
Prevalence of chronic kidney disease in the United States. JAMA (2007) 38.98
Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med (2006) 20.27
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet (2010) 18.36
Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis (2008) 15.04
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis (2003) 15.00
Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med (2009) 14.13
Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44
Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med (2002) 10.52
Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care (2002) 10.00
Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med (2012) 9.46
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int (2010) 9.25
Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem (2005) 8.93
Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol (2006) 8.61
The case of the misleading funnel plot. BMJ (2006) 8.26
Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol (2004) 8.21
Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med (2013) 7.98
Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis (2007) 7.86
Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation (2002) 7.25
Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis (2002) 7.03
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (2011) 6.80
Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int (2004) 6.32
Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26
Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int (2011) 6.01
Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol (2007) 6.00
Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int (2008) 5.90
Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials. JAMA (2002) 5.81
Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes? J Urol (2008) 5.70
Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med (2010) 5.48
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47
The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Intern Med (2005) 5.45
The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med (2002) 5.33
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int (2011) 5.25
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet (2012) 5.10
The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care (2007) 5.07
Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. Am J Kidney Dis (2007) 5.06
Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate. N Engl J Med (2015) 5.03
Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using StratusOCT. Invest Ophthalmol Vis Sci (2004) 4.81
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet (2012) 4.75
Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials. Lancet (2009) 4.73
Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int (2004) 4.51
The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med (2015) 4.49
A randomized trial of tai chi for fibromyalgia. N Engl J Med (2010) 4.37
Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis (2009) 4.30
A predictive model for progression of chronic kidney disease to kidney failure. JAMA (2011) 4.22
An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function. Kidney Int (2011) 3.96
Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis (2010) 3.87
Cystatin C identifies chronic kidney disease patients at higher risk for complications. J Am Soc Nephrol (2010) 3.85
Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation (2006) 3.85
Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial. Am J Kidney Dis (2011) 3.81
Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation (2004) 3.78
Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis. Ann Intern Med (2015) 3.75
Genetic loci influencing kidney function and chronic kidney disease. Nat Genet (2010) 3.75
Optical coherence tomography longitudinal evaluation of retinal nerve fiber layer thickness in glaucoma. Arch Ophthalmol (2005) 3.75
Patient awareness of chronic kidney disease: trends and predictors. Arch Intern Med (2008) 3.72
Testing for chronic kidney disease: a position statement from the National Kidney Foundation. Am J Kidney Dis (2007) 3.53
Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol (2003) 3.48
Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl (2004) 3.46
Why clinicians are natural bayesians. BMJ (2005) 3.41
Chronic kidney disease is common: what do we do next? Nephrol Dial Transplant (2008) 3.41
Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis (2008) 3.34
Evolving importance of kidney disease: from subspecialty to global health burden. Lancet (2013) 3.30
Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care (2007) 3.27
Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis. AIDS (2007) 3.22
National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics (2003) 3.10
Method of glomerular filtration rate estimation affects prediction of mortality risk. J Am Soc Nephrol (2009) 3.05
Change in the estimated glomerular filtration rate over time and risk of all-cause mortality. Kidney Int (2013) 3.05
Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol (2009) 3.00
Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values. Am J Kidney Dis (2011) 2.98
Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data. BMC Med Res Methodol (2009) 2.92
Uric acid and long-term outcomes in CKD. Am J Kidney Dis (2009) 2.86
Loss to analysis in randomized controlled trials in CKD. Am J Kidney Dis (2011) 2.85
Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. Am J Kidney Dis (2010) 2.83